Orphazyme appoints Christophe Bourdon as Chief Executive Officer

NEXT STORY
Global wireless health market size to record 23.10% CAGR through 2027
PREV STORY
Junshi Biosciences and AstraZeneca Announce Strategic Collaboration to Commercialize Toripalimab in China
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Bone Therapeutics SA : completes patient recruitment for pivotal interim analysis of Phase III Osteonecrosis trial with PREOB®

Regulated information Bone Therapeutics completes patient recruitment for pivotal interim analysis of Phase III ...

author_avatar
NASDAQ Market News

LAG-3Ig (IMP321) Demonstrates Positive Safety and Efficacy Qualities in Breast Cancer Clinical Trial

SYDNEY, Australia, June 04, 2017 (GLOBE NEWSWIRE) -- Breast cancer clinical trial demonstrates LAG-3Ig ...

author_avatar
NASDAQ Market News

HealthEC Announces New Chronic Care Management Partnerships

Practices Cite Optimized Reimbursements, Quick System Implementation and Simple Platform Navigation as Key Reasons ...

author_avatar
NASDAQ Market News